LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.09
Published: Nov 19, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at www.genecards.org. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science. GeneCards® is a comprehensive online database that provides concise genomic information on all known and predicted human genes. The recent GeneCards® release greatly enhances the representation of non-protein coding RNA genes based, among other sources, on the ENCODE Project, an international collaborative effort to identify all functional elements in the human genome sequence. With over 12 million page visits per year from hundreds of thousands of unique users worldwide, GeneCards® is accessed by professionals in academia, research hospitals, patent offices, and leading biotech and pharma companies. GeneCards® was developed, and is continuously enhanced by ongoing research, by the bioinformatics team at the Department of Molecular Genetics at the Weizmann Institute of Science in Israel, with principal investigator Professor Doron Lancet, head of the Crown Human Genome Center, and team leader Marilyn Safran.